Entera Bio(US:ENTX) Benzinga·2026-03-30 09:27Market Overview - U.S. stock futures rose on Monday after a significant sell-off on Friday, with major benchmark indices entering correction territory, falling more than 10% below their 52-week highs [1] - The S&P 500 marked a fifth consecutive weekly loss with a 2.1% drop, while the Nasdaq slid 3.2% over the week, and the Dow Jones Industrial Average retreated by 0.9% [7] Economic Indicators - The 10-year Treasury bond yielded 4.39%, and the two-year bond was at 3.89%, with a 96.4% likelihood of the Federal Reserve keeping interest rates unchanged in its April meeting [3] Company Performance - Palantir Technologies (PLTR): Maintains a weak price trend over the medium term but shows strong trends in the long and short medium terms, with a solid growth score [3] - Entera Bio Ltd. (ENTX): Dropped 8.85% after posting a loss of 6 cents per share for the fourth quarter, maintaining a weak price trend across all time frames [6] - TotalEnergies SE (TTE): Rose 2.01% after signing a long-term partnership with EDF Group for low-carbon electricity supply, maintaining a strong trend across all time frames [6] - Progress Software Corp. (PRGS): Up 0.04% with expected quarterly earnings of $1.57 per share on revenue of $246.40 million, maintaining a weak price trend across all time frames [13] Analyst Insights - Mohamed El-Erian warns of "stagflationary winds" affecting the U.S. economy and stock market, with major indices falling into correction territory and significant economic damage already evident [8] - El-Erian highlights energy supply shortages and persistent inflation undermining resilient growth, suggesting a deeper disruption to the global economy [9] - The classic 60/40 portfolio has suffered one of its worst monthly declines, indicating a shift in market dynamics [9] - Future market narratives are expected to revolve around "volatility, dispersion, and fragmentation," with central banks adopting a more hawkish stance [10]